TELONOSTIX LTD.

CF24 0DE (Wales)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£91,445

Feb 18 - Jan 19

Single Telomere Length Analysis: An Independent Prognostic Marker for Cancer Patients

Innovate UK award to TELONOSTIX LTD. and Duncan Baird

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}